GlassScriptPhysician profile
Lee B Pravder
NPI 1245218270
$4,388.35
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,778 · 2020: $1,284 · 2021: $1,327.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $774.32 | 2019-2021 | |
| Allergan, INC. | $557.95 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $524.10 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $446.62 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $352.56 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $274.70 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $271.50 | 2019 | |
| Abbvie INC. | $198.60 | 2021 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $175.00 | 2019 | |
| Bausch Health US, LLC | $155.56 | 2020-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $134.64 | 2021 | |
| Neurocrine Biosciences, INC. | $122.99 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $113.52 | 2019-2020 | |
| Neuronetics, INC. | $63.38 | 2019 | |
| Avanir Pharmaceuticals, INC. | $56.66 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $56.16 | 2019 | |
| Adlon Therapeutics L.P. | $42.53 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $39.24 | 2019-2020 | |
| Alfasigma USA, INC. | $16.91 | 2020 | |
| Merck Sharp & Dohme LLC | $11.41 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Pravder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.